Objective: In the antibiotic era, purulent pericarditis is a rare entity. However, there are still reports of cases of the disease, which is associated with high mortality, and most such cases are attributed to delayed diagnosis.
Introduction
Community-acquired pneumonia is associated with high morbidity and mortality worldwide.
Streptococcus pneumoniae is the main causative agent of such pneumonia, (1, 2) being responsible for 20-40% of cases. Albeit rare, purulent pericarditis can arise as a complication of pneumococcal pneumonia, significantly increasing morbidity and mortality, especially in patients with predisposing factors such as pre-existing pericardial effusion, immunosuppression, poorly-controlled diabetes mellitus, alcoholism, and chronic autoimmune diseases (e.g., rheumatoid arthritis), as well as in those with a history of cardiac surgery or chest trauma. (3) (4) (5) (6) Purulent pericarditis is an acute syndrome with a rapid course and a mortality rate approaching 100%. Even when the syndrome is diagnosed and treated promptly, the mortality rate is nearly 40%; death is most often from cardiac tamponade, with or without septic shock and constrictive pericarditis. (6) Here, we present a case series of pneumococcal pneumonia complicated by pericarditis, together with a brief review of the literature.
Neither the case reports nor the accompanying images contain any information that could be used in order to identify the patients. Surviving patients gave written informed consent.
On the sixth day, thoracic ultrasound showed volume loss of the right hemithorax with minimal pleural effusion. On the seventh day, an exploratory thoracotomy was performed and the findings were as follows: massive hepatization of the right lung; right pleural effusion and fibrosis; fibropurulent pericarditis with diffuse areas of pericardial thickening; and cardiac tamponade (500 cm 3 of purulent fluid). In addition, the vena cava, pulmonary veins, pulmonary arteries, aorta, and pericardium were engulfed by a fibrin layer; the pulmonary arteries were stiff and dilated. The patient died during the procedure. Death was the consequence of complicated sepsis caused by S. pneumoniae, serotype 1.
Case 2
A 53-year-old male with severe pneumonia was transferred from another hospital. He had dry cough, and chest pain. In the last 48 h, the symptoms had worsened, with tachycardia (140 bpm) and increasing dyspnea. The physical examination revealed hypotension (blood pressure, 90/60 mmHg) and tachypnea (26 breaths/min). Auscultation of the thorax revealed signs of rightsided pleural effusion. Laboratory data revealed marked elevation of inflammatory and infectious parameters: white blood cell count, 29. 10 A chest tube was inserted in order to drain the empyema. The patient reported some relief after the drainage; however, because of worsening of respiratory failure and the need to maintain a high FiO 2 (80%), he was admitted to the ICU. Microbiological studies, including urinary antigen testing, sputum culture, and culture of the pleural fluid, were positive for S. pneumoniae that was penicillin-and erythromycinsusceptible at minimum inhibitory concentrations < 0.25 µg/ml and < 0.03 µg/mL, respectively).
Echocardiography showed severe pericardial effusion (without signs of compression or hemodynamic impairment) and mild pulmonary hypertension with tricuspid regurgitation, although the other valves were functioning normally. A chest X-ray performed on the second day of hospitalization showed increased heart size and new pulmonary infiltrate. On the fourth day, tracheal intubation was required because the patient showed worsening of his clinical condition and deterioration of blood gas analysis. The patient was hemodynamically unstable, which called for aggressive measures. A second pericardiocentesis was performed and yielded 480 ml of seropurulent fluid. The condition of the patient improved after an infusion of norepinephrine (0.8 µg/kg per min). Unfortunately, he could not be stabilized. A chest X-ray performed on the second day of hospitalization showed progression of the disease process: an opacity involving nearly all of the right lung and further enlargement of cardiopericardial silhouette (Figure 2A ). Echocardiography showed severe pericardial effusion affecting the entire cardiac silhouette. Pericardiocentesis yielded 640 mL of exudative fluid, the culture of which was negative. Pericardial and thoracic drainage was performed; purulent fluid was obtained in a sterile manner from the chest drain. Examination of the pleural fluid showed a pH of 6.95, a glucose level of 5 mg/dL, proteins at 47.4 g/L, and an LDH content of 5,347 U/L. A second chest X-ray showed consolidation in the right lung, minimal pleural fluid, and a normal cardiac silhouette ( Figure 2B) . A urinary pneumococcal antigen test was negative. Pleural fluid culture was positive for S. pneumoniae that was susceptible to erythromycin, levofloxacin, and penicillin. The isolate was S. pneumoniae serotype 1.
The patient received empirical antibiotic treatment with the piperacillin-tazobactam combination (4.5 g/8 h) and levofloxacin (500 mg twice a day for 5 days). The latter was continued because the pneumococcus was susceptible to it. The patient was discharged on the twelfth day, after withdrawal of the pericardial and pleural drains.
Case 3
A 26-year-old female from Bahrain, with no relevant medical history, was brought to the emergency room. At presentation, the patient had cough with purulent expectoration, fever, and chest pain. She presented with tachypnea (34 breaths/min), hypotension (blood pressure, 85/55 mmHg), and tachycardia (144 bpm). Physical examination revealed bilateral crackles in the lower lung fields. Laboratory data were remarkable for elevation of inflammatory and infectious parameters: white blood cell count, 11 × 10 9 cells/L (68.2% neutrophils and 22.3% lymphocytes); platelet count, 573 × 10 9 /L; serum C-reactive protein, 6 mg/dL; serum sodium, 142 mEq/L; serum potassium, 3.7 mEq/L; and serum creatinine, 0.83 mg/dL.
A chest X-ray showed an enlarged cardiac silhouette and bilateral pulmonary opacities ( Figure 3A ). An echocardiogram revealed massive pericardial effusion with signs of cardiac tamponade. Pericardiocentesis was performed, yielding 600 cm 3 of exudative pericardial effusion.
fluid. A CT scan of the chest showed pneumonia in the left lower lobe, bilateral pleural effusion, and moderate pericardial effusion ( Figure 4B ). Thoracentesis was performed and yielded 1,050 mL of exudative fluid. Laboratory tests yielded the following data: white blood cell count, 11.78 × 10 9 cells/L (84.3% neutrophils, 4.3% lymphocytes, and 9.1% monocytes); platelet count, 512 × 10 9 /L; serum C-reactive protein, 31.27 mg/dL; serum creatinine, 0.94 mg/dL; serum sodium, 133 mEq/L; and serum potassium, 3.72 mEq/L. Examination of the pleural fluid showed a pH of 7.16, a glucose level of 4.5 mg/ dL, proteins at 49.1 g/L, and an LDH content of 1,385 U/L. A urinary pneumococcal antigen test was positive. Pleural fluid culture was positive for S. pneumoniae. The patient was treated for four weeks with amoxicillin-clavulanate (2.2 g/8 h, i.v.) plus levofloxacin (500 mg twice a day), together with a nonsteroidal anti-inflammatory drug (ibuprofen, 800 mg/day), after which there A CT scan showed bilateral pleural effusion, abundant pericardial effusion, and bilateral alveolar opacities ( Figure 3B ). The patient was admitted to the ICU. Supportive treatment was started, as was empirical antibiotic therapy with ceftriaxone (2 g/24 h) plus levofloxacin (500 mg twice per day), as well as a nonsteroidal anti-inflammatory drug (ibuprofen). It was necessary to drain the pericardial effusion multiple times. Various tests were performed: pleural fluid culture; blood culture; serological tests for atypical bacteria; and RT-PCR for respiratory viruses. In addition, we screened for tuberculosis (with a PPD test and enzyme-linked immunospot assay). A urinary pneumococcal antigen test was positive. Cytological studies of the pericardial effusion were negative for malignancy.
On the third day after admission, the clinical condition of the patient worsened and treatment was therefore started with methylprednisolone (1 mg/kg per day), which initially produced a promising response (decrease in the serum C-reactive protein level, a decrease in heart rate, and improvement of general status). On the fifth day, the condition of the patient deteriorated, with increasing pericardial effusion. The patient showed worsening respiratory distress, with an increase in the FiO 2 requirement (from 0.24 to 0.60). Drainage of the pleural effusion resulted in no improvement. At that time, she required intubation and mechanical ventilation. On the seventh day, she showed impaired ventilation, caused by decreased lung compliance and difficulties in maintaining oxygenation. Consequently, extracorporeal membrane oxygenation was started. However, because there was no subsequent improvement in the respiratory parameters, the extracorporeal membrane oxygenation was stopped and the patient died.
Case 4
A 57-year-old male presented with fever (38.9°C), chest pain, cough, and progressive dyspnea. The patient exhibited tachypnea (34 breaths/min) and tachycardia (134 bpm). Auscultation revealed decreased breath sounds in both lung bases, with crackles on the left. A chest X-ray revealed bilateral pleural opacities and enlargement of the cardiac silhouette ( Figure 4A ). Echocardiography showed moderate pericardial effusion affecting the entire cardiac silhouette. Pericardiocentesis yielded 250 mL of exudative Streptococcus pneumoniae-associated pneumonia complicated by purulent pericarditis: case series http://dx.doi.org/10.1590/S1806-37132015000000010 aggressive, long-term therapy. (11, 12) Pericarditis must be considered a possible complication in pneumococcal infections. (13) Cardiac tamponade is the most dangerous and common complication of pneumococcal pericarditis; it can be fatal, especially when its diagnosis is delayed. (14) (15) (16) (17) (18) When there are signs of infection and a chest X-ray shows an enlarged cardiac silhouette, echocardiography is mandatory. Aspiration of the purulent fluid by pericardiocentesis facilitates the diagnosis. (15) Recurrent pericardial effusion or constrictive pericarditis call for pericardial drainage or pericardiectomy. (14) (15) (16) (17) (18) In patients with pericarditis, urinary pneumococcal antigen tests can be successfully used in order to identify the causative agent. (19, 20) Recent studies have employed molecular analysis of pericardial fluid for that purpose. (19) The management of pneumococcal pericarditis involves prolonged (at least 4 weeks of) antimicrobial therapy, (14) in conjunction with pericardiocentesis. (15) When antibiotic therapy is used in combination with pericardiocentesis, mortality can be reduced to 20% or less. The complications of acute pericarditis typically appear early in its clinical course. (16) Each case in our series showed different clinical features and levels of severity. In three of the four cases, the main complication was cardiac tamponade. The low specificity of the symptoms makes early clinical diagnosis difficult. Too often, the diagnosis is made after the disease has already resulted in severe hemodynamic compromise. (12, 13, 16) Using pericardiocentesis to remove excess fluid from the pericardial sac and administering the appropriate antibiotic therapy are of paramount importance in reducing the mortality associated with purulent pericarditis. (11, 15, 21, 22) In conclusion, our case series demonstrates that, despite advances in diagnostic and treatment modalities, purulent pericarditis continues to be a serious complication of infection with S. pneumoniae. (23) Therefore, a diagnosis of S. pneumoniae-associated purulent pericarditis should be considered and investigated early in patients presenting with clinical deterioration and showing unsatisfactory improvement during conventional therapy.
was nearly complete resolution of the alterations seen on the chest X-ray and CT scan.
Discussion
Infectious etiologies are the cause of only 5% of all cases of pericardial effusion. (6) In most cases, S. pneumoniae infection spreads from an intrathoracic site, whereas the dissemination of Staphylococcus aureus is most often hematogenous. (6) (7) (8) Pneumococcal pericarditis is a rare syndrome. To our knowledge, only 20 cases were reported between 1980 and 2010, the prevalence of the syndrome being similar across all age groups. (8) (9) (10) Prior to the advent of antibiotic therapy, pneumococcal infection was the most common cause of purulent pericarditis. The fact that this is no longer the case might reflect the efficacy of penicillin therapy. (11) Mortality remains high in cases of pneumococcal pericarditis, even when patients receive 
